It is suggested that, in humans, FZD9 may be involved in the regulation of bone formation, because its deletion in the Williams-Beuren syndrome, a rare genetic disease with multiple manifestations, is associated with low bone mass [29], [30], [31]. This evidence concerns the gene FZD9 and hereditary disease.